Skip to main content

Table 4 Effect of Placebo, Phyllanthus emblica 250 mg and Phyllanthus emblica 500 mg on lipid profile

From: Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study

Parameter

Placebo (A)

(n = 18)

Phyllanthus emblica 250 mg (B)

(n = 20)

Phyllanthus emblica 500 mg (C)

(n = 21)

 

Baseline

12 weeks

Mean % change

Baseline

12 weeks

Mean % change

Baseline

12 weeks 12 weeks

Mean % change

TC (mg/dl)

179.16 ± 18.2

184.16 ± 20.8

2.78%

178.9 ± 21

165.7 ± 17.3*§

−7.17% †

183.48 ± 23.8

162.5 ± 18.9 *†

−11.11% †‡

HDL-C (mg/dl)

33.28 ± 2.74

33.29 ± 2.79

0.57%

32.75 ± 2.34

35.10 ± 4.24||¶

7.33% ¶

31.57 ± 2.44

38.48 ± 3.28 *†

22.16%†∞

LDL-C (mg/dl)

136.7 ± 16.02

141.6 ± 14.79

3.83%

133.2 ± 18.31

118.1 ± 17.9*†

−11.39%†

134.86 ± 12.24

105.52 ± 14.17*†

−21.80%†∞

TG (mg/dl)

184.3 ± 19.82

184.7 ± 21.62

0.18%

184.4 ± 28.05

165.9 ± 23.43*¶

−9.81%†

198.19 ± 31.84

157.24 ± 18.12*†

−19.22% †£

  1. Values expressed as mean ± SD
  2. SD Standard deviation, TC Total cholesterol, HDL-C High-density lipoprotein Cholesterol, LDL-C low-density lipoprotein cholesterol, TG Triglycerides
  3. *p < 0.001, ||p < 0.05 compared to baseline value. †p < 0.001, §p < 0.01, ¶ p < 0.05 compared to placebo (A vs B, A vs C).∞p < 0.001 B vs C, £p < 0.01 B vs C, ‡ p < 0.05: B vs C